T1	p 109 206	patients with primary Raynaud 's phenomenon in South Korea ; Korean Raynaud study ( KOARA study )
T2	p 356 411	primary Raynaud 's phenomenon ( RP ) in Korea . Primary
T3	p 1114 1131	Korean patients .
T4	p 1163 1184	primary RP patients .
T5	i 44 54	nifedipine
T6	i 78 99	Ginkgo biloba extract
T7	i 256 266	nifedipine
T8	i 287 300	nifedipine SR
T9	i 317 338	Ginkgo biloba extract
T10	i 456 475	nifedipine SR group
T11	i 495 522	Ginkgo biloba extract group
T12	i 1023 1036	nifedipine SR
T13	i 1061 1082	Ginkgo biloba extract
T14	o 21 29	efficacy
T15	o 34 40	safety
T16	o 233 252	efficacy and safety
T17	o 277 284	release
T18	o 673 691	the RP attack rate
T19	o 911 933	serious adverse events
T20	o 956 970	adverse events
T21	o 1023 1036	nifedipine SR